Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Advanced Esophageal Adenocarcinoma · Advanced Gastric Adenocarcinoma · Advanced Gastroesophageal Junction Adenocarcinoma · Clinical Stage II Esophageal Adenocarcinoma AJCC v8 · Clinical Stage III Esophageal Adenocarcinoma AJCC v8 · Clinical Stage III Gastric Cancer AJCC v8 · Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 · Clinical Stage IV Gastric Cancer AJCC v8 · Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 · Metastatic Esophageal Adenocarcinoma · Metastatic Gastric Adenocarcinoma · Metastatic Gastroesophageal Junction Adenocarcinoma · Unresectable Esophageal Adenocarcinoma · Unresectable Gastric Adenocarcinoma · Unresectable Gastroesophageal Junction Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Baptist Health Medical Center - Little Rock, Little Rock, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · 501-202-4715
    Contact: Principal Investigator (Rangaswamy Govindarajan)
  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · 501-686-8274
    Contact: Principal Investigator (Rangaswamy Govindarajan)
  • Kaiser Permanente-Anaheim, Anaheim, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Kaiser Permanente-Baldwin Park, Baldwin Park, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Kaiser Permanente-Bellflower, Bellflower, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Tower Cancer Research Foundation, Beverly Hills, California, United States

    Contact: Study coordinator (Site Public Contact) · towercancerresearch@toweroncology.com
    Contact: Principal Investigator (Jun Gong)
  • Kaiser Permanente Dublin, Dublin, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-Fontana, Fontana, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Kaiser Permanente-Fremont, Fremont, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente Fresno Orchard Plaza, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · 833-574-2273
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-Fresno, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente South Bay, Harbor City, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Kaiser Permanente-Irvine, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Site Public Contact) · cancercto@ucsd.edu · 858-822-5354
    Contact: Principal Investigator (Aaron Miller)
  • Keck Medicine of USC Koreatown, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 213-388-0908
    Contact: Principal Investigator (Syma Iqbal)
  • Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Syma Iqbal)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Syma Iqbal)
  • Kaiser Permanente West Los Angeles, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · Cancer.trial.info@cshs.org · 310-423-2133
    Contact: Principal Investigator (Jun Gong)
  • Kaiser Permanente- Modesto MOB II, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-Modesto, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Syma Iqbal)
  • Kaiser Permanente-Oakland, Oakland, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-Ontario, Ontario, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Kaiser Permanente - Panorama City, Panorama City, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Kaiser Permanente-Riverside, Riverside, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Kaiser Permanente-Roseville, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente Downtown Commons, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

  • Kaiser Permanente-South Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-San Diego Zion, San Diego, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Kaiser Permanente-San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente San Leandro, San Leandro, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-San Marcos, San Marcos, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • Kaiser San Rafael-Gallinas, San Rafael, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-South San Francisco, South San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-Vallejo, Vallejo, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kaiser Permanente-Woodland Hills, Woodland Hills, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Gary L. Buchschacher)
  • UCHealth Memorial Hospital Central, Colorado Springs, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 719-365-2406
    Contact: Principal Investigator (Shin Yin Lee)
  • Memorial Hospital North, Colorado Springs, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 719-364-6700
    Contact: Principal Investigator (Shin Yin Lee)
  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Shin Yin Lee)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@swog.org
    Contact: Principal Investigator (Shin Yin Lee)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@swog.org
    Contact: Principal Investigator (Shin Yin Lee)
  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Shin Yin Lee)
  • Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Beebe South Coastal Health Campus, Millville, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Beebe Health Campus, Rehoboth Beach, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-444-2223
    Contact: Principal Investigator (Reetu Mukherji)
  • AdventHealth Orlando, Orlando, Florida, United States

    Contact: Study coordinator (Site Public Contact) · FH.Cancer.Research@flhosp.org · 407-303-2090
    Contact: Principal Investigator (Mohamedtaki A. Tejani)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Oluwadunni Emiloju)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Oluwadunni Emiloju)
  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-851-7115
    Contact: Principal Investigator (Oluwadunni Emiloju)
  • Emory Decatur Hospital, Decatur, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrialsoncology@dekalbmedical.org · 440-778-1868
    Contact: Principal Investigator (Oluwadunni Emiloju)
  • Emory Johns Creek Hospital, Johns Creek, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · m.lisa.hwang@emory.edu · 404-778-5714
    Contact: Principal Investigator (Oluwadunni Emiloju)
  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · i.webster@hawaiicancercare.com · 808-524-6115
    Contact: Principal Investigator (Elizabeth S. Nakasone)
  • Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-532-0315
    Contact: Principal Investigator (Elizabeth S. Nakasone)
  • Queen's Medical Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-545-8548
    Contact: Principal Investigator (Elizabeth S. Nakasone)
  • Straub Clinic and Hospital, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-522-4333
    Contact: Principal Investigator (Elizabeth S. Nakasone)
  • Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-531-8521
    Contact: Principal Investigator (Elizabeth S. Nakasone)
  • Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · shelley.a.clark@kp.org · 808-432-5195
    Contact: Principal Investigator (Tilak K. Sundaresan)
  • Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-983-6090
    Contact: Principal Investigator (Elizabeth S. Nakasone)
  • Hawaii Cancer Care - Westridge, ‘Aiea, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · info@hawaiicancercare.com · 808-539-2273
    Contact: Principal Investigator (Elizabeth S. Nakasone)
  • Pali Momi Medical Center, ‘Aiea, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-486-6000
    Contact: Principal Investigator (Elizabeth S. Nakasone)
  • The Queen's Medical Center - West Oahu, ‘Ewa Beach, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · rohta@queens.org
    Contact: Principal Investigator (Elizabeth S. Nakasone)
  • Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Rush-Copley Medical Center, Aurora, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · RCMC_Cancer_Research@rush.edu · 630-978-6212
    Contact: Principal Investigator (Suparna Mantha)
  • Advocate Outpatient Center - Aurora, Aurora, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aah.org
    Contact: Principal Investigator (Edward S. James)
  • Advocate Good Shepherd Hospital, Barrington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-842-4847
    Contact: Principal Investigator (Edward S. James)
  • Illinois CancerCare-Bloomington, Bloomington, Illinois, United States

  • Illinois CancerCare-Canton, Canton, Illinois, United States

  • Illinois CancerCare-Carthage, Carthage, Illinois, United States

  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (Aparna Kalyan)
  • University of Illinois, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-355-3046
    Contact: Principal Investigator (Yolande Chen)
  • Swedish Covenant Hospital, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 773-878-8200
    Contact: Principal Investigator (Lauren A. Wiebe)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

  • Advocate Illinois Masonic Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 773-296-5360
    Contact: Principal Investigator (Edward S. James)
  • AMG Crystal Lake - Oncology, Crystal Lake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocate.com · 630-929-6129
    Contact: Principal Investigator (Edward S. James)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Aparna Kalyan)
  • Illinois CancerCare-Dixon, Dixon, Illinois, United States

  • Advocate Good Samaritan Hospital, Downers Grove, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Barbara.barhamand@advocatehealth.com · 630-275-1270
    Contact: Principal Investigator (Edward S. James)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Sherman Hospital, Elgin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-429-2907
    Contact: Principal Investigator (Edward S. James)
  • Illinois CancerCare-Eureka, Eureka, Illinois, United States

  • NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Lauren A. Wiebe)
  • Illinois CancerCare-Galesburg, Galesburg, Illinois, United States

  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Aparna Kalyan)
  • NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Lauren A. Wiebe)
  • Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (Aparna Kalyan)
  • Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (Aparna Kalyan)
  • Ingalls Memorial Hospital, Harvey, Illinois, United States

  • Advocate South Suburban Hospital, Hazel Crest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 708-799-9995
    Contact: Principal Investigator (Edward S. James)
  • NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Lauren A. Wiebe)
  • Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States

  • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@northwestern.edu
    Contact: Principal Investigator (Aparna Kalyan)
  • AMG Libertyville - Oncology, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Edward S. James)
  • Condell Memorial Hospital, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Edward S. James)
  • Illinois CancerCare-Macomb, Macomb, Illinois, United States

  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Oak Brook, Oak Brook, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Aparna Kalyan)
  • Advocate Christ Medical Center, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-323-8622
    Contact: Principal Investigator (Edward S. James)
  • Northwestern Medicine Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Aparna Kalyan)
  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

  • Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States

  • Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-384-3621
    Contact: Principal Investigator (Edward S. James)
  • Illinois CancerCare-Pekin, Pekin, Illinois, United States

  • Illinois CancerCare-Peoria, Peoria, Illinois, United States

  • Illinois CancerCare-Peru, Peru, Illinois, United States

  • Illinois CancerCare-Princeton, Princeton, Illinois, United States

  • Mercyhealth Cancer Institute - Rockford, Rockford, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · oncologyclinicaltrials@mhemail.org · 815-971-5858
    Contact: Principal Investigator (Mayur Narkhede)
  • UW Health Carbone Cancer Center Rockford, Rockford, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · lkline@uwhealth.org · 779-696-9378
    Contact: Principal Investigator (Fahrettin Covut)
  • Memorial Hospital East, Shiloh, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · dschwab@wustl.edu · 314-747-9912
    Contact: Principal Investigator (Patrick Grierson)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Aparna Kalyan)
  • Illinois CancerCare - Washington, Washington, Illinois, United States

  • Northwest Cancer Center - Crown Point, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@powershealth.org · 219-836-6879
    Contact: Principal Investigator (Suparna Mantha)
  • UChicago Medicine Northwest Indiana, Crown Point, Indiana, United States

  • Northwest Oncology LLC, Dyer, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-924-8178
    Contact: Principal Investigator (Suparna Mantha)
  • Northwest Cancer Center - Hobart, Hobart, Indiana, United States

  • Saint Mary Medical Center, Hobart, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@COMHS.org · 219-836-6875
    Contact: Principal Investigator (Suparna Mantha)
  • Saint Catherine Hospital, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · protocols@swog.org
    Contact: Principal Investigator (Suparna Mantha)
  • The Community Hospital, Munster, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-836-3349
    Contact: Principal Investigator (Suparna Mantha)
  • Women's Diagnostic Center - Munster, Munster, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · mnicholson@comhs.org · 219-934-8869
    Contact: Principal Investigator (Suparna Mantha)
  • Northwest Cancer Center - Valparaiso, Valparaiso, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@COMHS.org · 219-836-6875
    Contact: Principal Investigator (Suparna Mantha)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Saint Anthony Regional Hospital, Carroll, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · sbenson@iora.org · 515-689-7658
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Hospital, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-365-4673
    Contact: Principal Investigator (Deborah W. Wilbur)
  • Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-363-2690
    Contact: Principal Investigator (Deborah W. Wilbur)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Broadlawns Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-282-2200
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Healthcare Mission Cancer and Blood - Fort Dodge, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · trials@missioncancer.com · 515-282-2921
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • HaysMed, Hays, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-623-5774
    Contact: Principal Investigator (Gary C. Doolittle)
  • Lawrence Memorial Hospital, Lawrence, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.Norris@LMH.ORG · 785-505-2800
    Contact: Principal Investigator (Gary C. Doolittle)
  • The University of Kansas Cancer Center - Olathe, Olathe, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · OlatheCCResearch@kumc.edu · 913-588-1569
    Contact: Principal Investigator (Gary C. Doolittle)
  • Salina Regional Health Center, Salina, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · mleepers@srhc.com · 785-452-7038
    Contact: Principal Investigator (Gary C. Doolittle)
  • University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-295-8000
    Contact: Principal Investigator (Gary C. Doolittle)
  • CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • Ochsner Hematology Oncology North Shore - Covington (West Region), Covington, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · Cheryl.kesler@ochsner.org · 985-809-5668
    Contact: Principal Investigator (Jonathan D. Mizrahi)
  • Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · Elisemarie.curry@ochsner.org · 504-842-8084
    Contact: Principal Investigator (Jonathan D. Mizrahi)
  • UPMC Western Maryland, Cumberland, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 240-964-1400
    Contact: Principal Investigator (Anwaar Saeed)
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Trinity Health Medical Center - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Gazala Khan)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Trinity Health Medical Center - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Gazala Khan)
  • Henry Ford Medical Center-Fairlane, Dearborn, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Gazala Khan)
  • Henry Ford Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Gazala Khan)
  • OSF Saint Francis Hospital and Medical Group, Escanaba, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Cancer Hematology Centers - Flint, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Genesee Hematology Oncology PC, Flint, Michigan, United States

  • Genesys Hurley Cancer Institute, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Hurley Medical Center, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Allegiance Health, Jackson, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Gazala Khan)
  • University of Michigan Health - Sparrow Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · harsha.trivedi@umhsparrow.org · 517-364-3712
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Henry Ford Health Providence Novi Hospital, Novi, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kfife3@hfhs.org · 248-849-5332
    Contact: Principal Investigator (Gazala Khan)
  • Henry Ford Medical Center-Columbus, Novi, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Gazala Khan)
  • Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Henry Ford Health Providence Southfield Hospital, Southfield, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kfife3@hfhs.org · 248-849-5332
    Contact: Principal Investigator (Gazala Khan)
  • Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Gazala Khan)
  • Henry Ford Wyandotte Hospital, Wyandotte, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · nhay@hfhs.org
    Contact: Principal Investigator (Gazala Khan)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 218-333-5000
    Contact: Principal Investigator (Daniel Almquist)
  • Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Essentia Health - Deer River Clinic, Deer River, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Cancer Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Essentia Health Sandstone, Sandstone, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Virginia Clinic, Virginia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Patrick Grierson)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Patrick Grierson)
  • University Health Truman Medical Center, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 816-404-4375
    Contact: Principal Investigator (Gary C. Doolittle)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Patrick Grierson)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Patrick Grierson)
  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Patrick Grierson)
  • Community Hospital of Anaconda, Anaconda, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Vincent Frontier Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · 800-648-6274
    Contact: Principal Investigator (Patrick W. Cobb)
  • Bozeman Health Deaconess Hospital, Bozeman, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Logan Health Medical Center, Kalispell, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Laura L. Tenner)
  • Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-559-5600
    Contact: Principal Investigator (Laura L. Tenner)
  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Laura L. Tenner)
  • OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Renown Regional Medical Center, Reno, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · Renown-CRD@renown.org · 775-982-5050
    Contact: Principal Investigator (John A. Ellerton)
  • Jefferson Cherry Hill Hospital, Cherry Hill, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Daniel Lin)
  • Englewood Hospital and Medical Center, Englewood, New Jersey, United States

  • Sidney Kimmel Cancer Center Washington Township, Sewell, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Daniel Lin)
  • Lovelace Medical Center-Saint Joseph Square, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · ZPollock@salud.unm.edu · 505-272-0530
    Contact: Principal Investigator (Jessica Belmonte)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · HSC-ClinicalTrialInfo@salud.unm.edu · 505-925-0348
    Contact: Principal Investigator (Jessica Belmonte)
  • Northwell Health Imbert Cancer Center, Bay Shore, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Crystal Antoine-Pepeljugoski)
  • Roswell Park Cancer Institute, Buffalo, New York, United States

    Contact: Study coordinator (Site Public Contact) · askroswell@roswellpark.org · 800-767-9355
    Contact: Principal Investigator (Kannan Thanikachalam)
  • Glens Falls Hospital, Glens Falls, New York, United States

    Contact: Study coordinator (Site Public Contact) · 518-926-6700
    Contact: Principal Investigator (Charles Yun)
  • Northwell Health Cancer Institute at Huntington, Greenlawn, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Crystal Antoine-Pepeljugoski)
  • Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Crystal Antoine-Pepeljugoski)
  • NYU Langone Hospital - Long Island, Mineola, New York, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@nyulangone.org · 212-263-4432
    Contact: Principal Investigator (Jennifer W. Chuy)
  • Northern Westchester Hospital, Mount Kisco, New York, United States

    Contact: Study coordinator (Site Public Contact) · AMellor@northwell.edu · 914-666-1366
    Contact: Principal Investigator (Crystal Antoine-Pepeljugoski)
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@nyulangone.org
    Contact: Principal Investigator (Jennifer W. Chuy)
  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · 585-275-5830
    Contact: Principal Investigator (Richard F. Dunne)
  • Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States

    Contact: Study coordinator (Site Public Contact) · 914-366-1600
    Contact: Principal Investigator (Crystal Antoine-Pepeljugoski)
  • Cone Health Cancer Center at Asheboro, Asheboro, North Carolina, United States

  • Cone Health MedCenter Asheboro, Asheboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · stacey.phelps@conehealth.com · 336-832-0836
    Contact: Principal Investigator (Vinay K. Gudena)
  • Cone Health Cancer Center at Alamance Regional, Burlington, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · stacey.phelps@conehealth.com · 336-832-0836
    Contact: Principal Investigator (Vinay K. Gudena)
  • Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Cone Health Cancer Center, Greensboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · stacey.phelps@conehealth.com · 336-832-0836
    Contact: Principal Investigator (Vinay K. Gudena)
  • Cone Health Cancer Center at Drawbridge Parkway, Greensboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · stacey.phelps@conehealth.com · 336-832-0836
    Contact: Principal Investigator (Vinay K. Gudena)
  • Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 910-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jcwilliams@firsthealth.org · 910-715-3500
    Contact: Principal Investigator (Charles S. Kuzma)
  • Annie Penn Memorial Hospital, Reidsville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · stacey.phelps@conehealth.com · 336-832-0836
    Contact: Principal Investigator (Vinay K. Gudena)
  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Sanford Broadway Medical Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-234-6161
    Contact: Principal Investigator (Daniel Almquist)
  • Miami Valley Hospital South, Centerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • Miami Valley Hospital, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Premier Blood and Cancer Center, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-276-8320
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Miami Valley Hospital North, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Miami Valley Cancer Care and Infusion, Greenville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-569-7515
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Upper Valley Medical Center, Troy, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 877-231-4440
    Contact: Principal Investigator (Hassan Hatoum)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Hassan Hatoum)
  • Integris Southwest Medical Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Hassan Hatoum)
  • Integris Cancer Institute of Oklahoma, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 405-773-6613
    Contact: Principal Investigator (Hassan Hatoum)
  • Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 918-505-3200
    Contact: Principal Investigator (Mark B. Jennings)
  • Providence Newberg Medical Center, Newberg, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Providence Willamette Falls Medical Center, Oregon City, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Charles W. Drescher)
  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · trials@ohsu.edu · 503-494-1080
    Contact: Principal Investigator (Emerson Y. Chen)
  • Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Tareq Al baghdadi)
  • UPMC-Heritage Valley Health System Beaver, Beaver, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Anwaar Saeed)
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Tareq Al baghdadi)
  • Geisinger Medical Center, Danville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Mina Makary)
  • Geisinger Cancer Center Dickson City, Dickson City, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · hemoncctrials@geisinger.edu · 877-204-6081
    Contact: Principal Investigator (Mina Makary)
  • Pocono Medical Center, East Stroudsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Tareq Al baghdadi)
  • UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Anwaar Saeed)
  • UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 724-838-1900
    Contact: Principal Investigator (Anwaar Saeed)
  • UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · klitchfield@PINNACLEHEALTH.org · 717-724-6765
    Contact: Principal Investigator (Anwaar Saeed)
  • Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Tareq Al baghdadi)
  • UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 814-534-4724
    Contact: Principal Investigator (Anwaar Saeed)
  • Lancaster General Ann B Barshinger Cancer Institute, Lancaster, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · PMCancerResearch@pennmedicine.upenn.edu · 215-349-8245
    Contact: Principal Investigator (Efrat Dotan)
  • Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-374-8555
    Contact: Principal Investigator (Mina Makary)
  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Anwaar Saeed)
  • UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Anwaar Saeed)
  • Arnold Palmer Cancer Center Medical Oncology Norwin, N. Huntingdon, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Anwaar Saeed)
  • UPMC Hillman Cancer Center - New Castle, New Castle, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Anwaar Saeed)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Daniel Lin)
  • Jefferson Torresdale Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Daniel Lin)
  • UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-784-4900
    Contact: Principal Investigator (Anwaar Saeed)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Anwaar Saeed)
  • UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-367-6454
    Contact: Principal Investigator (Anwaar Saeed)
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-502-3920
    Contact: Principal Investigator (Anwaar Saeed)
  • Community Medical Center, Scranton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-703-4768
    Contact: Principal Investigator (Mina Makary)
  • UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 814-676-7900
    Contact: Principal Investigator (Anwaar Saeed)
  • UPMC Cancer Center-Uniontown, Uniontown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · protocols@swog.org
    Contact: Principal Investigator (Anwaar Saeed)
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Mina Makary)
  • Asplundh Cancer Pavilion, Willow Grove, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Daniel Lin)
  • Smilow Cancer Hospital Care Center - Westerly, Westerly, Rhode Island, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Yifei Zhang)
  • Ralph H Johnson VA Medical Center, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · ashley.salvo@va.gov · 843-789-7020
    Contact: Principal Investigator (Oleksandra Lupak)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (Toros Dincman)
  • Rapid City Regional Hospital, Rapid City, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · research@monument.health · 605-755-2370
    Contact: Principal Investigator (Abdel-Ghani Azzouqa)
  • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicTrialsSF@sanfordhealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsSF@SanfordHealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • University of Tennessee - Knoxville, Knoxville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 865-544-9773
    Contact: Principal Investigator (Saikrishna Gadde)
  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · burton@bcm.edu · 713-798-1354
    Contact: Principal Investigator (Karen Riggins)
  • Ben Taub General Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 713-873-2000
    Contact: Principal Investigator (Karen Riggins)
  • Farmington Health Center, Farmington, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Christopher D. Nevala-Plagemann)
  • University of Utah Sugarhouse Health Center, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Christopher D. Nevala-Plagemann)
  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Christopher D. Nevala-Plagemann)
  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners, Vermont, United States

  • University of Vermont Medical Center, Burlington, Vermont, United States

  • University of Vermont and State Agricultural College, Burlington, Vermont, United States

  • VCU Massey Cancer Center at Stony Point, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · ctoclinops@vcu.edu
    Contact: Principal Investigator (Jennifer L. Myers)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Jennifer L. Myers)
  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Juli.Alford@aspirus.org · 715-623-9869
    Contact: Principal Investigator (Andrew J. Huang)
  • Duluth Clinic Ashland, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora Saint Luke's South Shore, Cudahy, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Aurora Health Care Germantown Health Center, Germantown, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Aurora BayCare Medical Center, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • William S Middleton VA Medical Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 608-256-1901
    Contact: Principal Investigator (Sam J. Lubner)
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Nataliya V. Uboha)
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Nataliya V. Uboha)
  • Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Aspirus Medford Hospital, Medford, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Marshfield Medical Center - Minocqua, Minocqua, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora Cancer Care-Racine, Racine, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center, Rhinelander, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Sheboygan Physicians Group, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aspirus Cancer Care - Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Aurora Medical Center in Summit, Summit, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7632
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Aspirus Cancer Care-Wausau, Wausau, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 877-405-6866
    Contact: Principal Investigator (Andrew J. Huang)
  • Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora West Allis Medical Center, West Allis, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 715-422-7718
    Contact: Principal Investigator (Andrew J. Huang)
Study leads
  • Anwaar Saeed

    Principal Investigator

    SWOG Cancer Research Network